Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Validation of the Schistosomiasis Point-of-Care Circulating Cathodic Antigen (POC-CCA) Rapid Urine Test for Qualitative Detection of Schistosoma Japonicum

NCT03870204 is registered in ClinicalTrials.gov with Ina-Respond as lead sponsor.

NCT NCT03870204
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03870204 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Validation of the Schistosomiasis Point-of-Care Circulating Cathodic Antigen (POC-CCA) Rapid Urine Test for Qualitative Detection of Schistosoma Japonicum
Lead sponsor
Ina-Respond
Phase
Observational
Overall status
Completed
Start date
September 4, 2019
Completion date
July 2, 2020
Enrollment
186 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aged ≥2 years in schistosomiasis affected areas